Latest Insider Transactions at Nova Bay Pharmaceuticals, Inc. (NBY)
This section provides a real-time view of insider transactions for Nova Bay Pharmaceuticals, Inc. (NBY). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of NovaBay Pharmaceuticals, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of NovaBay Pharmaceuticals, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 08
2025
|
Poplar Point Capital Partners LP > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
300
+0.03%
|
$0
$0.46 P/Share
|
|
Apr 04
2025
|
Poplar Point Capital Partners LP > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
4,538
+0.44%
|
$0
$0.52 P/Share
|
|
Apr 03
2025
|
Poplar Point Capital Partners LP > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
22,976
+2.21%
|
$0
$0.56 P/Share
|
|
Apr 02
2025
|
Poplar Point Capital Partners LP > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
917
+0.09%
|
$0
$0.58 P/Share
|
|
Apr 01
2025
|
Poplar Point Capital Partners LP > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
19,915
+1.97%
|
$0
$0.58 P/Share
|
|
Mar 31
2025
|
Poplar Point Capital Partners LP > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
21,654
+2.18%
|
$0
$0.59 P/Share
|
|
Mar 28
2025
|
Poplar Point Capital Partners LP > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
49,400
+4.94%
|
$0
$0.61 P/Share
|
|
Mar 27
2025
|
Poplar Point Capital Partners LP > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
19,104
+1.04%
|
$0
$0.62 P/Share
|
|
Mar 26
2025
|
Poplar Point Capital Partners LP > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
13,292
+1.49%
|
$0
$0.61 P/Share
|
|
Mar 25
2025
|
Poplar Point Capital Partners LP > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
22,635
+2.54%
|
$0
$0.61 P/Share
|
|
Mar 24
2025
|
Poplar Point Capital Partners LP > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
100
+0.01%
|
$0
$0.6 P/Share
|
|
Mar 21
2025
|
Poplar Point Capital Partners LP > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
6,372
+0.75%
|
$0
$0.6 P/Share
|
|
Mar 20
2025
|
Poplar Point Capital Partners LP > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
5,320
+0.63%
|
$0
$0.61 P/Share
|
|
Mar 19
2025
|
Poplar Point Capital Partners LP > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
1,500
+0.18%
|
$0
$0.6 P/Share
|
|
Mar 18
2025
|
Poplar Point Capital Partners LP > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
24,000
+1.43%
|
$0
$0.63 P/Share
|
|
Mar 14
2025
|
Poplar Point Capital Partners LP > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
25,511
+3.06%
|
$0
$0.63 P/Share
|
|
Mar 13
2025
|
Poplar Point Capital Partners LP > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
34
+0.0%
|
$0
$0.64 P/Share
|
|
Mar 12
2025
|
Poplar Point Capital Partners LP > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
11,837
+1.49%
|
$0
$0.62 P/Share
|
|
Mar 11
2025
|
Poplar Point Capital Partners LP > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
2,148
+0.28%
|
$0
$0.58 P/Share
|
|
Mar 10
2025
|
Poplar Point Capital Partners LP > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
14,645
+1.87%
|
$0
$0.58 P/Share
|
|
Mar 07
2025
|
Poplar Point Capital Partners LP > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
102
+0.01%
|
$0
$0.55 P/Share
|
|
Mar 04
2025
|
Poplar Point Capital Partners LP > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
4,000
+0.53%
|
$0
$0.58 P/Share
|
|
Feb 28
2025
|
Poplar Point Capital Partners LP > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
13,108
+1.72%
|
$0
$0.6 P/Share
|
|
Feb 27
2025
|
Poplar Point Capital Partners LP > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
385
+0.05%
|
$0
$0.61 P/Share
|
|
Feb 26
2025
|
Poplar Point Capital Partners LP > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
6,302
+0.85%
|
$0
$0.61 P/Share
|
|
Feb 25
2025
|
Poplar Point Capital Partners LP > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
25,033
+3.31%
|
$0
$0.62 P/Share
|
|
Feb 24
2025
|
Poplar Point Capital Partners LP > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
450
+0.06%
|
$0
$0.62 P/Share
|
|
Feb 20
2025
|
Poplar Point Capital Partners LP > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
1,836
+0.26%
|
$0
$0.63 P/Share
|
|
Feb 19
2025
|
Poplar Point Capital Partners LP > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
49,664
+6.6%
|
$0
$0.67 P/Share
|
|
Feb 18
2025
|
Poplar Point Capital Partners LP > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
3,222
+0.49%
|
$0
$0.66 P/Share
|
|
Feb 04
2025
|
Poplar Point Capital Partners LP > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
26,718
+3.95%
|
$0
$0.64 P/Share
|
|
Feb 03
2025
|
Poplar Point Capital Partners LP > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
2,597
+0.41%
|
$0
$0.64 P/Share
|
|
Jan 31
2025
|
Poplar Point Capital Partners LP > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
70,685
+10.22%
|
$0
$0.65 P/Share
|
|
Jan 27
2025
|
Poplar Point Capital Partners LP > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
31,703
+5.45%
|
$0
$0.69 P/Share
|
|
May 11
2023
|
Yongxiang Zheng Director |
BUY
Exercise of conversion of derivative security
|
Direct |
858
+50.0%
|
-
|
|
May 11
2023
|
Julie Garlikov Director |
BUY
Exercise of conversion of derivative security
|
Direct |
858
+50.0%
|
-
|
|
May 11
2023
|
Swan Sit Director |
BUY
Exercise of conversion of derivative security
|
Direct |
858
+33.33%
|
-
|
|
May 11
2023
|
Mijia Wu Director |
BUY
Exercise of conversion of derivative security
|
Direct |
858
+33.33%
|
-
|
|
May 11
2023
|
Yenyou Zheng Director |
BUY
Exercise of conversion of derivative security
|
Direct |
858
+33.33%
|
-
|
|
May 11
2023
|
Paul E. Freiman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
858
+33.33%
|
-
|
|
Dec 06
2022
|
Jeffrey Kunin President, DERMAdoctor, LLC |
SELL
Open market or private sale
|
Indirect |
1
-100.0%
|
$1
$1.81 P/Share
|
|
Dec 06
2022
|
Audrey Kunin Chief Product Officer |
SELL
Open market or private sale
|
Indirect |
1
-100.0%
|
$1
$1.81 P/Share
|
|
Nov 21
2022
|
Jeffrey Kunin President, DERMAdoctor, LLC |
SELL
Open market or private sale
|
Indirect |
5,960
-100.0%
|
$11,920
$2.1 P/Share
|
|
Nov 21
2022
|
Audrey Kunin Chief Product Officer |
SELL
Open market or private sale
|
Indirect |
5,960
-100.0%
|
$11,920
$2.1 P/Share
|
|
Sep 14
2022
|
Jeffrey Kunin President, DERMAdoctor, LLC |
SELL
Open market or private sale
|
Indirect |
291,368
-58.27%
|
$0
$0.16 P/Share
|
|
Sep 14
2022
|
Audrey Kunin Chief Product Officer |
SELL
Open market or private sale
|
Indirect |
291,368
-58.27%
|
$0
$0.16 P/Share
|
|
Sep 14
2022
|
Justin Hall CEO, GC and Director |
BUY
Open market or private purchase
|
Direct |
10,000
+10.73%
|
$0
$0.15 P/Share
|
|
May 21
2022
|
Swan Sit Director |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+50.0%
|
-
|
|
May 21
2022
|
Paul E. Freiman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+50.0%
|
-
|
|
May 21
2022
|
Yenyou Zheng Director |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+50.0%
|
-
|